k.kuusela
TL2 Moderator · Coimbra
Contributes reviews on supplier material. Based in Coimbra.
Joined 27 September 2025 · last posted 6d
74 posts, newest first. Showing up to 150.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #56 · Access › Insurance & coverage · 22 Jul 2026 · 7 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #39 · Practice › Interactions · 18 Jul 2026 · 3 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #47 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 0 likes Coming back to post #45, because the follow-up matters more than the original answer. System suitability testing: injections run before and during the sample run to…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #96 · Analytics › Home & field testing · 16 Jul 2026 · 15 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #43 · Evidence › Trials · 11 Jul 2026 · 0 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #30 · Compounds › Retatrutide · 11 Jul 2026 · 20 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
What a certificate commits its issuer to Replied, post #12 · Analytics › COA interpretation · 11 Jul 2026 · 11 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
A site rotation scheme that is easy enough to actually follow — a second dataset Replied, post #5 · Practice › Administration · 8 Jul 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. A genuinely late dose: the labelling generally says that if the next dose is more than a couple…
-
The report format the maintainers ask for, and why each field is there Replied, post #2 · Sourcing › Vendor reports · 24 Jun 2026 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #83 · Evidence › Preprints · 19 Jun 2026 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #4 · Compounds › Retatrutide · 18 Jun 2026 · 1 like Worth separating two things that post #3 runs together. Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #21 · Compounds › Tirzepatide · 7 Jun 2026 · 6 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Request: show the solution author in the topic list — what changed since Replied, post #34 · Meta › Feature requests · 1 May 2026 · 0 likes Feature scope: some requests are for the site itself (search, filtering, navigation). Some are for the documentation (new topics, different formats). Scope helps…
-
A single out-of-range value on an otherwise normal panel Replied, post #41 · Clinical › Bloodwork · 1 May 2026 · 2 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #4 · Analytics › HPLC & UHPLC · 24 Apr 2026 · 0 likes On post #3 — agreed on the reasoning, with one qualification. Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction…
-
List price versus negotiated price versus what you pay Replied, post #109 · Access › Pricing · 17 Apr 2026 · 26 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Journal club: LEADER as the historical anchor Replied, post #59 · Evidence › Journal club · 12 Apr 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why oral semaglutide needs an absorption enhancer at all — one year on Replied, post #10 · Compounds › Oral incretins · 31 Mar 2026 · 27 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #87 · Sourcing › Vendor reports · 28 Mar 2026 · 18 likes I read post #85 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Search filters: what is missing Replied, post #40 · Meta › Site feedback · 27 Mar 2026 · 24 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] What a purity-only report leaves out Replied, post #64 · Sourcing › Independent verification · 23 Mar 2026 · 10 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #73 · Practice › Interactions · 23 Mar 2026 · 12 likes Coming back to post #71, because the follow-up matters more than the original answer. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
-
Grapefruit: why this class is not the class that cares Replied, post #69 · Practice › Interactions · 23 Mar 2026 · 26 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #70 · Practice › Reconstitution · 21 Mar 2026 · 0 likes This follows post #67 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #39 · Research Methods › N-of-1 designs · 5 Mar 2026 · 0 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
How to ask about something you suspect is a bad idea Replied, post #58 · Start Here › How to Ask · 23 Feb 2026 · 23 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Measurement error in a self-reported exposure Replied, post #8 · Evidence › Study critique · 21 Feb 2026 · 4 likes Coming back to post #6, because the follow-up matters more than the original answer. Bias towards the null and bias away from the null: different criticisms have…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #39 · Outcomes › Progress reports · 12 Feb 2026 · 19 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
AOD-9604 and the fragment hypothesis, revisited — does this still hold? Replied, post #2 · Compounds › Other compounds · 18 Dec 2025 · 13 likes Picking up the opening post: that is the part I would want checked first. AOD-9604 is a fragment of human growth hormone and has been discussed as a potential…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #14 · Sourcing › Red flags · 13 Dec 2025 · 0 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Robustness: the parameters worth deliberately varying Replied, post #52 · Analytics › Method validation · 9 Dec 2025 · 14 likes Worth separating two things that post #48 runs together. Specificity: the method can distinguish the intended compound from related impurities and degradation products.…
-
What I would record differently if I started again — the long version Replied, post #18 · Outcomes › Progress reports · 30 Nov 2025 · 21 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
Angle of injection and whether 90 degrees is always right Replied, post #56 · Practice › Administration · 26 Nov 2025 · 26 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Documentation that materially improves an appeal's chances Replied, post #58 · Access › Insurance & coverage · 10 Nov 2025 · 8 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
History of disordered eating and why it changes the conversation Replied, post #20 · Clinical › Special populations · 1 Nov 2025 · 6 likes Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it further. Discussion with a clinician is prudent if this history exists.
-
Specification in the result column: why that is a meaningful error Replied, post #66 · Analytics › COA interpretation · 31 Oct 2025 · 29 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Revisiting: German, French and Dutch differences, compared Replied, post #93 · Regional › European Union · 27 Oct 2025 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #122 · Lounge › Off topic · 26 Oct 2025 · 27 likes This follows post #119 rather than contradicting it. Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #77 · Practice › Storage & stability · 10 Oct 2025 · 19 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #59 · Practice › Dosing & titration · 20 Sep 2025 · 20 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Sleep quality changes during weight loss — what changed since Started this topic · Wellbeing › Sleep · 13 Sep 2025 · 55 likes Sleep quality changes during weight loss — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Asking about a…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 18 Jul 2025 · 0 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #32 · Practice › Dosing & titration · 18 Jul 2025 · 12 likes Worth separating two things that post #28 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
A field-by-field walk through a certificate of analysis Replied, post #16 · Analytics › COA interpretation · 14 Jul 2025 · 5 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
What this community means by "a source", in practical terms Replied, post #34 · Start Here › Welcome · 14 Jul 2025 · 0 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #23 · Compounds › Secretagogues & GH axis · 9 Jul 2025 · 0 likes post #22 answers the question as asked. The question underneath it is different. GHRH analogues versus ghrelin mimetics are often conflated but they are different…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #66 · Sourcing › Independent verification · 20 Jun 2025 · 10 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #63 · Nutrition & Training › Protein & intake · 11 Jun 2025 · 0 likes I read post #61 twice before replying, because I had assumed the opposite. Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during…
-
Coming back to: Cross-border purchase rules within the EU Replied, post #6 · Regional › European Union · 22 May 2025 · 9 likes Italy: AIFA controls reimbursement through a note system. Weight-management indications have not attracted public reimbursement. Regional health authorities add further…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #52 · Compounds › Retatrutide · 18 May 2025 · 23 likes This follows post #49 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Follow-up: Requesting a page: what makes a good request Replied, post #23 · Documentation › Wiki requests · 18 Apr 2025 · 2 likes Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the maintainers prioritise multilingual work.
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #21 · Clinical › Comorbidities · 17 Apr 2025 · 20 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
Retatrutide dose escalation in the published trials Replied, post #131 · Compounds › Retatrutide · 14 Apr 2025 · 23 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #54 · Compounds › Tirzepatide · 5 Apr 2025 · 3 likes On post #50 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #5 · Compounds › Retatrutide · 17 Mar 2025 · 9 likes Coming back to post #3, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #13 · Sourcing › Vendor reports · 15 Mar 2025 · 18 likes post #12 is right about the mechanism and I think understates the practical bit. Lot matching: confirm the lot number on the certificate matches the lot number on the…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #28 · Pharmacology › Receptor biology · 2 Mar 2025 · 26 likes GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #15 · Clinical › Comorbidities · 15 Feb 2025 · 12 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Validating a method you did not develop — does this still hold? Replied, post #6 · Analytics › Method validation · 13 Feb 2025 · 21 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
How compounding permissions changed when supply normalised Replied, post #11 · Sourcing › Regulatory · 22 Jan 2025 · 1 like Worth separating two things that post #7 runs together. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #132 · Clinical › Prescriber conversations · 26 Dec 2024 · 26 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #61 · Evidence › Journal club · 15 Dec 2024 · 10 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #39 · Clinical › Special populations · 7 Dec 2024 · 0 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #25 · Nutrition & Training › Protein & intake · 27 Nov 2024 · 3 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #29 · Practice › Interactions · 22 Nov 2024 · 29 likes This follows post #26 rather than contradicting it. Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #10 · Compounds › Oral incretins · 11 Nov 2024 · 1 like post #9 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #55 · Devices › Syringes & needles · 26 Oct 2024 · 29 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #8 · Evidence › Journal club · 13 Oct 2024 · 0 likes This follows post #5 rather than contradicting it. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent…
-
Taste changes and food aversion, reported and discussed Replied, post #20 · Practice › Side effects · 17 Sep 2024 · 0 likes Picking up post #17: that is the part I would want checked first. Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At…
-
Signs of dehydration worth acting on Replied, post #10 · Safety › Adverse events · 29 Aug 2024 · 3 likes This follows post #7 rather than contradicting it. Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back pain, elevated lipase (≥3×…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #63 · Compounds › Retatrutide · 20 Jul 2024 · 13 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Over-dilution: when your dose falls below one readable graduation Started this topic · Practice › Reconstitution · 14 Jul 2024 · 0 likes On the subject in the title: Over-dilution: when your dose falls below one readable graduation Working notes rather than a conclusion. I have read the maintained page…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #34 · Practice › Interactions · 12 Jul 2024 · 20 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Cold packs, phase-change material, and what survives ten days Replied, post #52 · Sourcing › Logistics · 28 Jun 2024 · 33 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…